Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) criteria are the gold standard for risk‐stratifying patients with metastatic renal cell cancer (mRCC). We developed a novel risk scoring system for patients with mRCC treated with immune checkpoint inhibitors (I...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Martini, Dylan J., Liu, Yuan, Shabto, Julie M., Carthon, Bradley C., Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Kissick, Haydn T., Harris, Wayne B., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2019
Assuntos:
Genitourinary Cancer
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066702/
https://ncbi.nlm.nih.gov/pubmed/32162798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0578
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares